Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel F Tyndale

Showing results (61-70 of 359) with videos related to

Pageof 36
Sort By:
Addiction Biology|May 28, 2016
Brain CYP2B induction can decrease nicotine levels in the brainKristine L P Garcia, Anh Dzung Lê, Rachel F Tyndale
Neuropharmacology|November 29, 2005
CYP2B6 is expressed in African Green monkey brain and is induced by chronic nicotine treatmentAnna M Lee, Sharon Miksys, Roberta Palmour, et al.
Behavioural Brain Research|August 8, 2014
Effect of food training and training dose on nicotine self-administration in ratsKristine L P Garcia, Anh Dzung Lê, Rachel F Tyndale
Biochemical Pharmacology|April 30, 2013
First demonstration that brain CYP2D-mediated opiate metabolic activation alters analgesia in vivoKaidi Zhou, Jibran Y Khokhar, Bin Zhao, et al.
British Journal of Pharmacology|October 25, 2019
Propranolol is a mechanism-based inhibitor of CYP2D and CYP2D6 in humanized CYP2D6-transgenic mice: Effects on activity and drug responsesEdgor Cole Tolledo, Sharon Miksys, Frank J Gonzalez, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 22, 2005
Human CYP2D6 and mouse CYP2Ds: organ distribution in a humanized mouse modelSharon L Miksys, Connie Cheung, Frank J Gonzalez, et al.
Pharmacogenetics and Genomics|March 7, 2013
CYP2A6 slow nicotine metabolism is associated with increased quitting by adolescent smokersMeghan J Chenoweth, Jennifer O'Loughlin, Marie-Pierre Sylvestre, et al.
Neuropharmacology|May 4, 2013
Ethanol self-administration and nicotine treatment induce brain levels of CYP2B6 and CYP2E1 in African green monkeysCharmaine S Ferguson, Sharon Miksys, Roberta M Palmour, et al.
Human Psychopharmacology|December 31, 2009
Effect of metabolic blockade on the psychoactive effects of dextromethorphanLaurie A Zawertailo, Rachel F Tyndale, U Busto, et al.
European Journal of Clinical Pharmacology|December 17, 2009
Hepatic CYP2A6 levels and nicotine metabolism: impact of genetic, physiological, environmental, and epigenetic factorsNael Al Koudsi, Ewa B Hoffmann, Abbas Assadzadeh, et al.
Pageof 36

Showing results (61-70 of 359) with videos related to

Sort By:
Pageof 36
Addiction Biology|May 28, 2016
Brain CYP2B induction can decrease nicotine levels in the brainKristine L P Garcia, Anh Dzung Lê, Rachel F Tyndale
Neuropharmacology|November 29, 2005
CYP2B6 is expressed in African Green monkey brain and is induced by chronic nicotine treatmentAnna M Lee, Sharon Miksys, Roberta Palmour, et al.
Behavioural Brain Research|August 8, 2014
Effect of food training and training dose on nicotine self-administration in ratsKristine L P Garcia, Anh Dzung Lê, Rachel F Tyndale
Biochemical Pharmacology|April 30, 2013
First demonstration that brain CYP2D-mediated opiate metabolic activation alters analgesia in vivoKaidi Zhou, Jibran Y Khokhar, Bin Zhao, et al.
British Journal of Pharmacology|October 25, 2019
Propranolol is a mechanism-based inhibitor of CYP2D and CYP2D6 in humanized CYP2D6-transgenic mice: Effects on activity and drug responsesEdgor Cole Tolledo, Sharon Miksys, Frank J Gonzalez, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 22, 2005
Human CYP2D6 and mouse CYP2Ds: organ distribution in a humanized mouse modelSharon L Miksys, Connie Cheung, Frank J Gonzalez, et al.
Pharmacogenetics and Genomics|March 7, 2013
CYP2A6 slow nicotine metabolism is associated with increased quitting by adolescent smokersMeghan J Chenoweth, Jennifer O'Loughlin, Marie-Pierre Sylvestre, et al.
Neuropharmacology|May 4, 2013
Ethanol self-administration and nicotine treatment induce brain levels of CYP2B6 and CYP2E1 in African green monkeysCharmaine S Ferguson, Sharon Miksys, Roberta M Palmour, et al.
Human Psychopharmacology|December 31, 2009
Effect of metabolic blockade on the psychoactive effects of dextromethorphanLaurie A Zawertailo, Rachel F Tyndale, U Busto, et al.
European Journal of Clinical Pharmacology|December 17, 2009
Hepatic CYP2A6 levels and nicotine metabolism: impact of genetic, physiological, environmental, and epigenetic factorsNael Al Koudsi, Ewa B Hoffmann, Abbas Assadzadeh, et al.
Pageof 36